憂鬱症治療藥物市場：依藥物類型、依適應症、依配銷通路、依地區

Depression Therapeutics Market, By Drug Type, By Indication, By Distribution Channel, and By Geography

出版日期: 2023年09月05日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2023年全球憂鬱症藥物市場規模為129億美元，預測期內（2023-2030年）年複合成長率為4.5%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	129億美元
實績資料	2018-2021	預測期	2023-2030
預測期年複合成長率	4.50%	2030年市場規模預測	176億美元

2023 年依藥物類型分類的憂鬱症藥物全球市場佔有率(%)

抗憂鬱藥物是緩解憂鬱症狀的藥物，也用於治療其他疾病。抗憂鬱症可以治療憂鬱症和其他心理健康問題的症狀。然而，並非總是能夠解決原因。醫生經常開抗憂鬱症和談話療法來解決心理健康問題的根源。抗憂鬱症有多種類型。它們作用於幾乎相同的大腦化學物質並產生相似的效果。然而，有些抗憂鬱症對某些人的效果比其他人更好。

市場動態

製藥業的主要參與者透過進行各種臨床試驗和研究活動來專注於藥物的開發。因此，市場參與者活性化的研發活動預計將在預測期內推動全球憂鬱症藥物市場的成長。例如，2022年11月，專注於為受中樞神經系統疾病罹患的人們恢復希望的生物技術公司Autobahn Therapeutics宣布，將在健康志願者中開始ABX-002的1期臨床給藥。 ABX-002是一種甲狀腺受體BETA （ TR Hui）促效劑，對改善腦功能具有很強的抗憂鬱症作用，目前正在研究對MDD患者輔助性治療的可能性。

本次測試的主要特點

本報告詳細分析了全球憂鬱症治療藥物市場，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率(CAGR)。它揭示了各個部門市場的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
它根據公司亮點、產品系列、主要亮點、業績和策略等參數，介紹了全球憂鬱症治療藥物市場的主要企業。
該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、經營團隊升級、市場擴張和行銷策略做出明智的資訊。
全球憂鬱症治療藥物市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球憂鬱症治療藥物市場的各種策略矩陣，將有助於相關人員做出決策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 12.9 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	4.50%	2030 Value Projection:	US$ 17.6 Bn

Depression therapeutics are medications that can help relieve the symptoms of depression and are also used in the treatment of some other conditions. Antidepressants can treat the symptoms of depression or other mental health problems. But they don't always deal with the causes. Doctors will often prescribe them alongside talking therapy, to help deal with the causes of mental health problems. There are several different types of antidepressants. They mostly affect the same brain chemicals and cause similar effects. But some people may respond to certain antidepressants better than others.

The different types are:

Selective Serotonin Reuptake Inhibitors (SSRIs)
Serotonin and Noradrenaline Reuptake Inhibitors (SNRIs)
Tricyclics and tricyclic-related drugs
Monoamine Oxidase Inhibitors (MAOIs)
Others

Market Dynamics

The key players in the pharmaceutical industry are focusing on the development of drugs by conducting various clinical trials and research operations. Thus, increasing research and development activities by market players are expected to drive the growth of the global depression therapeutics market over the forecast period. For instance, in November 2022, Autobahn Therapeutics, a biotechnology company focused on restoring hope for people affected by CNS disorders, announced the initiation of dosing in the company's Phase 1 clinical trial of ABX-002 in healthy volunteers. ABX-002 is a potent and selective brain-boosting thyroid receptor beta (TRβ) agonist that Autobahn is evaluating as a potential adjunctive treatment for people with major depressive disorder (MDD) who are experiencing an inadequate response to their antidepressant.

Key features of the study:

This report provides an in-depth analysis of the global depression therapeutics market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global depression therapeutics market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Johnson & Johnson, GlaxoSmithKline plc., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited., Eli Lilly and Company, Sanofi S.A., Pfizer, Inc., Allergan plc., H. Lundbeck A/S, Alkermes, Allergan, Novartis AG, Biogen, Sage Therapeutics, Inc., and AbbVie Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global depression therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global depression therapeutics market.

Detailed Segmentation:

Global Depression Therapeutics Market, By Drug Type:
- Selective Serotonin Reuptake Inhibitors (SSRIs)
- Selective Norepinephrine Reuptake Inhibitors (SNRIs)
- Serotonin Modulators
- Tricyclic & Tetracyclic Antidepressants
- Atypical Antidepressants
- Antidepressants
- Antipsychotics
- Others
Global Depression Therapeutics Market, By Indication:
- Major Depressive Disorder (MDD)
- Bipolar Disorder
- Dysthymic Disorder
- Postpartum Depression
- Seasonal Affective Disorder (SAD)
- Premenstrual Dysphoric Disorder (PMDD)
- Others
Global Depression Therapeutics Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Depression Therapeutics Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Johnson & JohnsonGlaxoSmithKline plc.
- Otsuka Pharmaceutical Co., Ltd.
- Takeda Pharmaceutical Company Limited.
- Eli Lilly and Company
- Sanofi S.A.
- Pfizer, Inc.
- Allergan plc.
- H. Lundbeck A/S
- Alkermes
- Allergan
- Novartis AG
- Biogen
- Sage Therapeutics, Inc.
- AbbVie Inc.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Indication
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics

Drivers
Restraints
Market Opportunities
- Impact Analysis
- Recent Drug Launches
- Epidemiology
- Pipeline Analysis
- Distribution Landscape
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis

4. Global Depression Therapeutics Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Depression Therapeutics Market, By Drug Type, 2018 - 2030, (US$ Bn)

Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018-2030
Segment Trends
Antidepressants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Selective Serotonin Reuptake Inhibitors (SSRIs)
Selective Norepinephrine Reuptake Inhibitors (SNRIs)
Serotonin Modulators
Tricyclic & Tetracyclic Antidepressants
Atypical Antidepressants
Antipsychotics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends

6. Global Depression Therapeutics Market, By Indication, 2018 - 2030, (US$ Bn)

Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018-2030
Segment Trends
Major Depressive Disorder (MDD)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Bipolar Disorder
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Dysthymic Disorder
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Postpartum Depression
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Seasonal Affective Disorder (SAD)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Premenstrual Dysphoric Disorder (PMDD)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends

7. Global Depression Therapeutics Market, By Distribution Channel, 2018 - 2030, (US$ Bn)

Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018-2030
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

8. Global Depression Therapeutics Market, By Region, 2018 - 2030, (US$ Bn)

Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018-2030
Segment Trends
North America
Introduction
Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country/ Region, 2018 -2030, (US$ Bn)
North Africa
Central Africa
South Africa